NCT04539327 2026-03-18Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO StudyGrupo Español de Investigación en Cáncer de OvarioCompleted51 enrolled 28 charts
NCT05116189 2026-03-09KEYNOTE-B96Merck Sharp & Dohme LLCPhase 3 Active not recruiting643 enrolled 17 charts 1 FDA